TIFFANY JOCO: Open Payments
NPI 1780153775 · MANSFIELD, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$427 in 17 payments from 6 companies in 2025. Trend: 2023 $464 · 2024 $738 · 2025 $427
Food & beverage: $427
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 3 | $162 |
| Novartis Pharmaceuticals Corporation | 9 | $161 |
| Amgen Inc. | 2 | $41 |
| Medtronic, Inc. | 1 | $25 |
| Esperion Therapeutics, Inc. | 1 | $20 |
| AstraZeneca Pharmaceuticals LP | 1 | $18 |
Products named: LEQVIO, CAMZYOS, REPATHA, SYMPLICITY G3, NEXLETOL, FARXIGA.
Industry payments across TX — which companies pay providers there.
